Ozempic

Novo Nordisk will invest $4.1 billion to develop a new manufacturing facility in the U.S., which will be used to boost production for the company's weight ...

Doctors in Denmark should limit how many packs of Novo Nordisk's Ozempic diabetes drug patients can pick up at one time, the Danish Patient Safety Authority ...

Novo Nordisk, the Danish pharmaceutical company behind the diabetes and weight-loss drugs Ozempic and Wegovy, will build a new manufacturing facility in ...

(WNCN) — Novo Nordisk announced Monday its plans to invest $4.1 billion to build a second manufacturing facility in Clayton to expand and produce current and ...

By Eleanor Laise. New North Carolina facility to produce obesity treatment Wegovy and other injectable drugs. Novo Nordisk on Monday said it will invest ...

The new US site is the latest in a series of multibillion-dollar investments into ratcheting up supply for diabetes drug Ozempic and weight-loss medicine Wegovy ...

Novo Nordisk will spend $4.1B to construct a second fill-finish plant at its sprawling campus in Clayton, N.C., where it makes Ozempic and Wegovy.

COPENHAGEN (Reuters) - Doctors in Denmark should limit how many packs of Novo Nordisk's Ozempic diabetes drug patients can pick up at one time, ...

"Novo Nordisk to build $4.1 billion manufacturing plant in North Carolina to meet demand for Ozempic and Wegovy, creating 1000 new jobs."

Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its popular...

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy.

Weight loss and diabetes drugs work by mimicking our 'fullness' hormone, but doctors believe you can boost it through diet alone.

Novo said it now plans to pour $6.8 billion into production investments this year, up from $3.9 billion in 2023.

At 43, Chauche was prescribed a weight-loss medication called Wegovy—one of a new class of drugs that mimic a hormone responsible for insulin production. She ...

As the company faces supply and cost criticisms, Danish drugmaker Novo Nordisk A/S says it will spend $4.1 billion to build a manufacturing plant in Clayton ...

Public employees in West Virginia who took the drugs lost weight and were healthier, and some are despondent that the state is canceling a program to help ...

Other research suggests the increasingly popular weight loss drugs fail to preserve muscle.

This alert follows a similar one from the European Medicines Agency in October 2023 amid a rise in demand for the diabetes medication that, in turn, ...

Construction on the Novo Nordisk facility is expected to be completed in phases between 2027 and 2029. Prev Next. Construction is expected to be completed ...

A spokesperson for Novo Nordisk, the maker of Ozempic, said the company is working with the FDA to crack down on counterfeits. Some members of Congress say high ...